arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2204.05877physics.bio-ph
收藏

过继细胞转移治疗肿瘤反应的计算模型

Computational model for tumor response to adoptive cell transfer therapy

Luciana Melina Luque, Carlos Manuel Carlevaro, Enrique Rodríguez-Lomba, Enrique Lomba

摘要:

开发有效的过继性细胞转移疗法(ACT)(特别是针对基因工程改造的T细胞受体(TCR)和嵌合抗原受体(CAR)T细胞)的障碍之一是靶抗原异质性。认为肿瘤内异质性是治疗抗性和治疗失败的主要决定因素之一。虽然了解抗原异质性对于有效的治疗是重要的,但良好的治疗策略可以提高治疗效率。在这项工作中,我们引入了一个基于代理的模型,合理化的结果,两种类型的ACT治疗异质性肿瘤:抗原特异性ACT治疗和多抗原识别ACT治疗。我们发现,一剂抗原特异性ACT治疗有望缩小肿瘤大小和肿瘤生长速度,但可能不足以完全消除肿瘤;第二剂也能缩小肿瘤大小和肿瘤生长速度,但由于肿瘤内异质性,其效果不如前一剂。此外,一个有趣的新兴现象的结果从模拟,即形成一个盾牌状结构的细胞与低癌蛋白表达。这种保护层可以保护癌蛋白高表达的细胞。另一方面,我们的研究表明,多抗原识别ACT疗法应用越早,其效果越好。事实上,它可以完全消除肿瘤。根据我们的结果,很明显,适当的治疗策略可以提高治疗效果。在这个方向上,我们的计算方法提供了一个框架,在不同的情况下模拟治疗组合,并探索成功和不成功的治疗的特点。

英文摘要:

One of the barriers to the development of effective adoptive cell transfer therapies (ACT), specifically for genetically engineered T-cell receptors (TCRs), and chimeric antigen receptor (CAR) T-cells, is target antigen heterogeneity. It is thought that intratumor heterogeneity is one of the leading determinants of therapeutic resistance and treatment failure. While understanding antigen heterogeneity is important for effective therapeutics, a good therapy strategy could enhance the therapy efficiency. In this work we introduce an agent-based model to rationalize the outcomes of two types of ACT therapies over heterogeneous tumors: antigen specific ACT therapy and multi-antigen recognition ACT therapy. We found that one dose of antigen specific ACT therapy should be expected to reduce the tumor size as well as its growth rate, however it may not be enough to completely eliminate it. A second dose also reduced the tumor size as well as the tumor growth rate, but, due to the intratumor heterogeneity, it turned out to be less effective than the previous dose. Moreover, an interesting emergent phenomenon results from the simulations, namely the formation of a shield-like structure of cells with low oncoprotein expression. This shield turns out to protect cells with high oncoprotein expression. On the other hand, our studies suggest that the earlier the multi-antigen recognition ACT therapy is applied, the more efficient it turns. In fact, it could completely eliminate the tumor. Based on our results, it is clear that a proper therapeutic strategy could enhance the therapies outcomes. In that direction, our computational approach provides a framework to model treatment combinations in different scenarios and explore the characteristics of successful and unsuccessful treatments.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑